Distinguishing hypertensive cardiomyopathy from cardiac amyloidosis in hypertensive patients with heart failure: a CMR study with histological confirmation.

MLA

Gil, Katarzyna Elzbieta, et al. “Distinguishing Hypertensive Cardiomyopathy from Cardiac Amyloidosis in Hypertensive Patients with Heart Failure: A CMR Study with Histological Confirmation.” The International Journal of Cardiovascular Imaging, vol. 40, no. 12, Dec. 2024, pp. 2559–70. EBSCOhost, https://doi.org/10.1007/s10554-024-03262-0.

APA

Gil, K. E., Truong, V., Liu, C., Ibrahim, D. Y., Mikrut, K., Satoskar, A., Varghese, J., Kahwash, R., & Han, Y. (2024). Distinguishing hypertensive cardiomyopathy from cardiac amyloidosis in hypertensive patients with heart failure: a CMR study with histological confirmation. The International Journal of Cardiovascular Imaging, 40(12), 2559–2570. https://doi.org/10.1007/s10554-024-03262-0

Chicago

Gil, Katarzyna Elzbieta, Vien Truong, Chuanfen Liu, Dalia Y Ibrahim, Katarzyna Mikrut, Anjali Satoskar, Juliet Varghese, Rami Kahwash, and Yuchi Han. 2024. “Distinguishing Hypertensive Cardiomyopathy from Cardiac Amyloidosis in Hypertensive Patients with Heart Failure: A CMR Study with Histological Confirmation.” The International Journal of Cardiovascular Imaging 40 (12): 2559–70. doi:10.1007/s10554-024-03262-0.